Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Prepaid Assets (2016 - 2025)

Haemonetics has reported Prepaid Assets over the past 16 years, most recently at $63.4 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 44.11% year-over-year to $63.4 million; the TTM value through Dec 2025 reached $63.4 million, down 44.11%, while the annual FY2025 figure was $60.4 million, 8.93% down from the prior year.
  • Prepaid Assets for Q4 2025 was $63.4 million at Haemonetics, up from $60.0 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $113.5 million in Q4 2024 and troughed at $31.9 million in Q1 2022.
  • A 5-year average of $55.6 million and a median of $53.1 million in 2021 define the central range for Prepaid Assets.
  • Biggest five-year swings in Prepaid Assets: soared 104.91% in 2024 and later tumbled 44.11% in 2025.
  • Year by year, Prepaid Assets stood at $42.9 million in 2021, then increased by 6.05% to $45.5 million in 2022, then increased by 21.82% to $55.4 million in 2023, then soared by 104.91% to $113.5 million in 2024, then tumbled by 44.11% to $63.4 million in 2025.
  • Business Quant data shows Prepaid Assets for HAE at $63.4 million in Q4 2025, $60.0 million in Q3 2025, and $59.0 million in Q2 2025.